What Constitutes a Material Adverse Effect: The Latest Judicial Pronouncement
The English High Court of Justice decision in the BM Brazil case sheds light on common-law courts’ interpretation of material adverse effect (MAE) clauses.
The English High Court of Justice decision in the BM Brazil case sheds light on common-law courts’ interpretation of material adverse effect (MAE) clauses.
Though the rise of AI has bolstered threats to confidentiality of client data, time-tested data protection best practices can address many risks.
Cyber insurance is a key safety net for businesses. Understand types of coverage and steps to secure the right policy as AI introduces new risks.
Trends since the landmark decision include a rise in Section 1981 claims and increased suits against corporate diversity, equity, and inclusion initiatives.
From medical devices that operate using AI to groundbreaking therapies, life sciences diligence needs deep IP knowledge—especially for patent and FDA risks.
Changes in Venezuelan insurance law and U.S. sanctions complicate cross-border sale of insurance in ways U.S. financial services companies must attend to.
CTA reporting companies face a dilemma when a beneficial owner will not provide the required information in time: file an incomplete BOIR, or delay filing?
Even when an acquired entity is not incorporated in India, if it has a subsidiary there, the deal can involve foreign exchange regulations and other issues.